Culture Medium Optimization and Probiotic Characteristics Evaluation of Lactobacillus rhamnosus LR-ZB1107-01

doi:10.12141/j.issn.1000-565X.200437

Abstract

Abstract:

In order to increase the number of organisms per unit volume of fermentation broth and provide a basis for the development and application of Lactobacillus rhamnosus ZB1107-01 (LR-ZB1107-01) obtained in the early stage of the study, which is well tolerated by simulated gastrointestinal tract, this paper initially performs medium optimization and probiotic properties investigation of the strain. First, the growth curve of strain LR-ZB1107-01 in MRS medium was measured to clarify its growth pattern in liquid medium. Next, the number of viable bacteria in the fermentation broth of strain LR-ZB1107-01 was used as the detection index, and different kinds of nitrogen sources, carbon sources and growth factors were examined unilaterally to determine the optimal medium components, and response surface tests were conducted to optimize the medium ratios and select the best medium. Finally, the in vitro safety of the nitro reductase activity and amino decarboxylase activity was evaluated. The results show that the viable bacteria count concentration can reach 8.56×10⁸ CFU/mL, if three nutrients and contents that significantly affected the viable bacteria count are changed as follows: the addition of D-isoascorbic acid at 0.02%, magnesium sulfate at 0.12% and peptone at 3%, based on the glucose content of MRS medium at 2% and combined with the optimized culture conditions. The viable bacteria count is about 10.7 times higher than that in MRS medium. The in vitro safety evaluation results indicate that LR-ZB1107-01 is negative for both nitroreductase and amino acid decarboxylase, suggesting that the strain has a certain safety profile. This achievement has a certain guiding effect on the industrial production of probiotic strains and the subsequent development of products.

Key words: Lactobacillus rhamnosus, culture medium optimization, response surface design, probiotic characteristics

CLC Number:

TS201.3

XU Xilin, ZHAO Sibo, ZHENG Liuqing, et al. Culture Medium Optimization and Probiotic Characteristics Evaluation of Lactobacillus rhamnosus LR-ZB1107-01[J]. Journal of South China University of Technology(Natural Science Edition), 2022, 50(8): 21-29.

Figures/Tables 11

Fig.1

Fig.2

Fig.3

Fig.4

Table 1

Table 2

Table 3

Table 4

Fig.5

Fig.6

Fig.7

References 17

1	王子建．鼠李糖乳杆菌制剂治疗牛奶蛋白过敏患儿对其胃肠道功能和免疫功能的影响［J］．医学理论与实践，2021，34（23）：4134-4135．
	WANG Zijian ．Effects of Lactobacillus rhamnosus preparations on gastrointestinal and immune functions in children with milk protein allergy［J］．Medical Theory and Practice，2021，34（23）：4134-4135．
2	BERNI C R， SANGWAN N， STEFKA A T，et al ． Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants［J］．The ISME Journal，2016，10（3）：742-750．
3	FONG W， LI Q， YU J ．Gut microbiota modulation：a novel strategy for prevention and treatment of colorectal cancer［J］．Oncogene，2020，39（26）：4925-4943．
4	MONTEAGUDO-MERA A， RASTALL R A， GIBSON G R，et al ．Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health［J］．Applied Microbiology and Biotechnology，2019，103（16）：6463-6472．
5	FORESTIER C， DE CHAMPS C， VATOUX C，et al ．Probiotic activities of Lactobacillus casei rhamnosus：in vitro adherence to intestinal cells and antimicrobial pro-perties［J］．Research in Microbiology，2001，152（2）：167-173．
6	TOMARO-DUCHESNEAU C， JONES M L， SHAH D，et al ．Cholesterol assimilation by Lactobacillus probiotic bacteria：an in vitro investigation［J］．BioMed Research International，2014，1（1）：380316/1-9．
7	H-S YOON， JU J-H， KIM H，et al ． Lactobacillus rhamnosus BFE 5264 and Lactobacillus plantarum NR74 promote cholesterol excretion through the up-regulation of ABCG5/8 in Caco-2 cells［J］．Probiotics and Antimicrobial Proteins，2011，3（3/4）：194-203．
8	SANCHEZ M， DARIMONT C， DRAPEAU V，et al ．Effect of Lactobacillus rhamnosus CGMCC1. 3724 supplementation on weight loss and maintenance in obese men and women［J］．British Journal of Nutrition，2014，111（8）：1507-1519．
9	SHU Q， GILL H S ．Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 （DR20™） against Escherichia coli O157：H7 infection in mice［J］．FEMS Immunology & Medical Microbiology，2002，34（1）：59-64．
10	KARA S S， VOLKAN B， ERTEN I ． Lactobacillus rhamnosus GG can protect malnourished children［J］．Beneficial Microbes，2019，10（3）：237-244．
11	SLYKERMAN R F， HOOD F， WICKENS K，et al ．Effect of Lactobacillus rhamnosus HN001 in pregnancy on postpartum pymptoms of depression and anxiety：a randomised double-blind placebo-controlled trial［J］．EBioMedicine，2017，24：159-165．
12	SCHIRALDI C， ADDUCI V， VALLI V，et al ．High cell density cultivation of probiotics and lactic acid production［J］．Biotechnology and Bioengineering，2003，82（2）：213-222．
13	TERPOU A， PAPADAKI A， LAPPA I，et al ．Probio-tics in food systems：significance and emerging strategies towards improved viability and delivery of enhanced beneficial value［J］．Nutrients，2019，11（7）：1591-1600．
14	DONG Z， GU L， ZHANG J，et al ．Optimisation for high cell density cultivation of Lactobacillus salivarius BBE 09-18 with response surface methodology［J］．International Dairy Journal，2014，34（2）：230-236．
15	谢为天，徐春厚，冯晓杰．鼠李糖乳杆菌LT22发酵培养基优化［J］．安徽农业科学，2012，40（12）：7155-7156，7239．
	XIE Wei-tian， XU Chun-hou， FENG Xiao-jie ．Optimization of fermentation medium for Lactobacillus rhamnosus LT22［J］．Anhui Agricultural Science，2012，40（12）：7155-7156，7239．
16	顾旭峰，艾连中，宋馨，等．两株干酪乳杆菌的安全性评价［J］．食品与发酵科技，2015，51（2）：63-65．
	GU Xu-feng， AI Lian-zhong， SONG Xin，et al ．Safety evaluation of two strains of Lactobacillus casei ［J］．Food and Fermentation Science and Technology，2015，51（2）：63-65．
17	MARCOBAL A， DE LAS RIVAS B， LANDETE J M，et al ．Tyramine and phenylethylamine biosynthesis by food bacteria［J］．Crit Rev Food Sci Nutr，2012，52（5）：448-467．

试验号	A/%	B/%	C/%	D/%	E/%	F/%	G/%	H/%	I/%	活菌数/（10⁸CFU·mL^-1）
1	0	4	4	0.015	0.12	0.04	0.07	0.02	0.03	5.27 ± 0.09
2	0	4	4	0.025	0.08	0.02	0.05	0.04	0.03	8.50 ± 0.04
3	0	4	3	0.025	0.12	0.02	0.07	0.04	0.05	6.90 ± 0.11
4	3	3	3	0.015	0.12	0.02	0.07	0.04	0.03	8.40 ± 0.14
5	0	3	3	0.025	0.08	0.04	0.07	0.02	0.05	7.13 ± 0.13
6	0	3	3	0.015	0.08	0.02	0.05	0.02	0.03	10.7 ± 0.05
7	3	4	3	0.015	0.08	0.04	0.05	0.04	0.05	7.30 ± 0.07
8	3	4	4	0.015	0.08	0.04	0.07	0.02	0.05	8.20 ± 0.08
9	3	3	4	0.025	0.12	0.02	0.05	0.02	0.05	6.97 ± 0.14
10	3	3	4	0.025	0.08	0.04	0.07	0.04	0.03	6.40 ± 0.05
11	0	3	4	0.015	0.12	0.04	0.05	0.04	0.05	6.20 ± 0.15
12	3	4	3	0.025	0.12	0.04	0.05	0.02	0.03	6.90 ± 0.04

变量	校正结果	均方	贡献度/%
A	0.004 1	0.000 5	0.068
B	-0.023 8	0.001 7	2.295
C	-0.056 9	0.009 7	13.138
D	-0.022 5	0.001 5	2.055
E	-0.072 7	0.015 9	21.449
F	-0.100 5	0.030 3	40.963
G	-0.039 7	0.004 7	6.400
H	-0.007 6	0.000 2	0.233
I	-0.024 2	0.001 8	2.366

试验号	A/%	B/%	C/%	活菌数/（10⁸CFU·mL^-1）
1	0.03	0.08	3.00	2.86 ± 0.17
2	0.02	0.10	3.00	5.10 ± 0.12
3	0.03	0.12	3.00	5.16 ± 0.18
4	0.04	0.10	3.00	2.78 ± 0.08
5	0.04	0.08	3.50	2.89 ± 0.24
6	0.02	0.08	3.50	3.60 ± 0.24
7	0.03	0.10	3.50	3.60 ± 0.21
8	0.04	0.10	4.00	2.88 ± 0.19
9	0.03	0.10	3.50	3.60 ± 0.24
10	0.03	0.10	3.50	3.60 ± 0.25
11	0.03	0.12	4.00	5.17 ± 0.14
12	0.02	0.10	4.00	2.99 ± 0.16
13	0.02	0.12	3.50	5.67 ± 0.07
14	0.03	0.10	3.50	3.60 ± 0.28
15	0.04	0.12	3.50	5.53 ± 0.22
16	0.03	0.10	3.50	3.60 ± 0.29
17	0.03	0.08	4.00	3.60 ± 0.29

来源	总和	自由度	均方	F值	P值
模型	1 688.20	9	187.58	7.81	0.006 5
A	187.23	1	187.23	7.79	0.026 9
B	996.11	1	996.11	41.46	0.000 4
C	16.72	1	16.72	0.69	0.431 7
AB	18.35	1	18.35	0.76	0.411 1
AC	153.18	1	153.18	6.38	0.039 5
BC	24.60	1	24.60	1.02	0.345 3
A²	2.78	1	2.78	0.11	0.743 9
B²	269.74	1	269.74	11.23	0.012 2
C²	29.78	1	29.78	1.24	0.302 3
残差	168.19	7	24.03
失拟项	168.19	3	56.06	5.74	0.062
净误差	0.000	4	0.00
总误差	1 856.39	16